Immunotherapy works by boosting the immune system or enhancing its ability to recognize cancer cells as harmful. The main types of immunotherapy include:

• Checkpoint Inhibitors: Block proteins that prevent immune cells from attacking cancer
• CAR-T Cell Therapy: Genetically modifies a patient’s T-cells to target cancer cells
• Monoclonal Antibodies: Bind to specific targets on cancer cells, marking them for immune destruction
• Cancer Vaccines: Stimulate the immune system to recognize and attack tumor cells

• Precision Targeting: Directly involves the immune system to attack cancer cells
• Fewer Side Effects: Compared to traditional chemotherapy, healthy tissues are mostly spared
• Long-Lasting Effects: Can provide sustained immune memory to prevent cancer recurrence
• Combination Potential: Often used with chemotherapy, targeted therapy, or radiotherapy for enhanced outcomes

Immunotherapy is effective for various cancers, including:

• Leukemia and lymphoma
• Melanoma
• Lung cancer
• Kidney and bladder cancers
• Other solid tumors expressing specific immune targets

• Consultation and Assessment: Oncologists evaluate cancer type, stage, and immune markers.
• Treatment Planning: Personalized immunotherapy regimen designed based on patient profile.
• Administration: Delivered intravenously or through specialized cell-based therapies such as CAR-T.
• Monitoring: Patients are closely monitored for response and side effects.
• Follow-up: Regular assessments ensure treatment effectiveness and long-term outcomes.

Immunotherapy is administered under expert supervision with strict monitoring to manage side effects and optimize safety. Our oncology team provides continuous support and counseling throughout the treatment journey.

• Advanced immunotherapy options including CAR-T and monoclonal antibody therapies
• Experienced team of hematologists and medical oncologists
• State-of-the-art infrastructure for safe and precise treatment
• Integrated care with chemotherapy, targeted therapy, and radiotherapy programs